Botulinum toxin as an effective treatment of clozapine-induced hypersalivation

Psychopharmacology

Volumn 173, Issue 1-2, 2004, Pages 229-230

  Kahl, Kai G ^a   Hagenah, Johann ^a   Zapf, Silke ^a   Trillenberg, Peter ^a   Klein, Christine ^a   Lencer, Rebekka ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Botulinum toxin; Hypersalivation; Neuroleptics; Sialorrhea

Indexed keywords

ATROPINE; ATYPICAL ANTIPSYCHOTIC AGENT; BOTULINUM TOXIN A; CLOZAPINE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; HUMAN; HYPERSALIVATION; LABORATORY TEST; MALE; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; PSYCHOSOCIAL WITHDRAWAL; SIDE EFFECT;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; CLOZAPINE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; SIALORRHEA; TREATMENT OUTCOME;

EID: 19244365186     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-1803-0     Document Type: Article

References (5)

1. Ellies M, Laskawi R, Rohrbach-Volland S, Arglebe C (2003) Upto-date report of botulinum toxin therapy in patients with drooling caused by different etiologies. J Oral Maxillofac Surg 61:454-457
2. Kerner J (1817) Vergiftung durch verdorbene Würste. Tübinger Blätt Neurowissenschaften Arzneykunde 3:1-25
3. Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, Bourgeois M, Chouinard G, Islam MZ, Kane J, Krishnan R, Lindenmayer JP, Potkin S (2003) Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 60:82-91
4. Miller DD (2000) Review and management of clozapine side effects. J Clin Psychiatry 61:14-19
5. Rogers DP, Pharm D, Shramko JK (2000) Therapeutic options in the treatment of clozapine-induced sialorrhea. Pharmacotherapy 20:1092-1095